IADR Announces the Winners of 2016 Innovation in Oral Care Awards Recipients
FOR IMMEDIATE RELEASE
IADR contact: Ingrid L. Thomas
+1.703.548.0066 or firstname.lastname@example.org
June 21, 2016
Alexandria, Va., USA – The International Association for Dental Research (IADR) is excited to announce the 2016 winners of the annual IADR Innovation in Oral Care Awards. The three prestigious awards recognize research in innovative oral care technologies that may maintain and improve oral health and quality of life. Each of the three 2016 winners will receive a $75,000 unrestricted research grant, which is funded by GlaxoSmithKline and administered by IADR. The winners will be announced at the Opening Ceremonies of the 94th General Session & Exhibition of the IADR, held in conjunction with the 3rd Meeting of the IADR Asia Pacific Region and the 35th Annual Meeting of the IADR Korean Division, Wednesday, June 22, 2016, in Seoul, Republic of Korea, and presented at an awards reception that evening.
The 2016 IADR Innovation in Oral Care Awards recipients are:
Catherine Ovitt and co-investigator Vyacheslan Korshunov, University of Rochester, New York, USA, for the study titled “Localized Delivery of Amifostine to Enhance Salivary Gland Radioprotection.” The objectives of this study are to determine if localized amifostine administration can enhance radioprotection and long-term function of salivary gland acinar cells; and to investigate whether effects on systemic and local vasculature are mitigated by localized administration of amifostine to salivary glands. Successful validation of this approach would provide compelling evidence for modification of the current treatment protocol, in order to limit the incidence of radiation-induced xerostomia and improve the quality of life for cancer survivors.
Nicholas Jakubovics and co-investigators Michael Hall, Philip Preshaw and Grant Burgess, Newcastle University, Newcastle upon Tyne, England, UK, for the study titled “Control of Oral Biofilms Using a Natural Marine Microbial Enzyme.” This project aims to develop a novel approach for oral hygiene based on the application of an enzyme, NucB from Bacillus licheniformis, that degrades the microbial biofilm matrix.
H.M.H.N. Bandara and co-investigator Lakshman Samaranayake, both from the University of Queensland, Australia, and co-investigator Hugh Smyth, The University of Texas at Austin, USA, for a study titled “Novel Quorum Sensing-based Liposomal Drug Delivery Against Oral Candida Biofilms.” The proposed novel liposomal antifungal delivery system will significantly increase the drug penetration and lead to more effective suppression of Candida biofilms, and eventually resolution of oral and mucosal candidiasis.
Supported by GlaxoSmithKline, each recipient receives $75,000 to support research focusing on new innovative oral care technologies that can be used routinely by the public to maintain and improve oral health and the quality of life.
“IADR is honored that GlaxoSmithKline has supported the Innovation in Oral Care Awards for 13 years,” said IADR President Marc Heft. “This generous contribution from GSK will afford deserving teams of scientists opportunities to develop innovative concepts that aim to improve oral health for the global population.”
In its 13th year of award support, GlaxoSmithKline has contributed more than $3 million to the IADR Innovation in Oral Care Awards program. IADR administers and awards the grants through a rigorous peer-review process, which was chaired this year by Margherita Fontana, University of Michigan, Ann Arbor, USA.
About the International and American Associations for Dental Research
The International Association for Dental Research (IADR) is a nonprofit organization with nearly 10,500 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge for the improvement of oral health worldwide, (2) supporting and representing the oral health research community, and (3) facilitating the communication and application of research findings. To learn more, visit www.iadr.org.